Patent No. EP2949666 (titled "Human Anti-Alpha-Synuclein Antibodies") was filed by Biogen Neuroscience on Dec 21, 2009. The application was issued on Dec 19, 2018.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Get instant alerts for new documents